Skip to main content

Table 3 Survival data for the four cohorts

From: Is cytoreductive surgery and hyperthermic intraperitoneal chemotherapy indicated in hepatobiliary malignancies?

 Overall survivalp valueProgression-free survivalp value
Median, months1-year (%)3-year (%) Median, months1-year (%)3-year (%) 
HCC (n = 9)42 [7–44]5 (74)3 (59)0.1887 [3–14]2 (27)0 (0)0.550
CCa (n = 4)19 [15–NR]3 (75)0 (0) 10 [7–15]1 (25)0 (0) 
GBC (n = 3)8 [2–13]1 (50)0 (0) 2 [1–13]1 (33)0 (0) 
PCa (n = 1)15 [N/A]1 (100)0 (0) 15 [N/A]1 (100)0 (0) 
  1. HCC hepatocellular carcinoma, CCa cholangiocarcinoma, GBC gallbladder cancer, PCa pancreatic cancer, NR not reached